Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo de conferência |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/57932 |
Resumo: | Apresentador do material: Vitória Fernandes de Castro Tipo de material apresentado: Pôster |
id |
CRUZ_952b5cc57a063ce959054c57dc584dd7 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/57932 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Castro, Vitória Fernandes deAquino, Carolina LessaLima, EryksonChaves, BeatrizReis, RafaellaAlmeida, Vinícius Cotta deEsteves, Gabriela SantosMedeiros, Marco Alberto2023-04-24T14:04:43Z2023-04-24T14:04:43Z2023CASTRO, V. F. de et al. Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICALS, 7., 2023, Rio de Janeiro. Annals of the Symposium: building pathways to accelerated the development of the national tecnhnological innovation ecosystem. Rio de Janeiro: Instituto de Tecnologia em Imunobiológicos, 2023. p. 42.https://www.arca.fiocruz.br/handle/icict/5793210.35259/isi.2023_57932Apresentador do material: Vitória Fernandes de Castro Tipo de material apresentado: PôsterOs autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fiocruz/Ceará.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fiocruz/Ceará.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.engEsclerose MúltiplaBioterapêuticoAnticorpos MonoclonaisMultiple SclerosisBiotherapeuticMonoclonal AntibodiesEsclerose MúltiplaAnticorpos MonoclonaisDevelopment and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/57932/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALAnais7thISI2023_42.pdfAnais7thISI2023_42.pdfapplication/pdf177891https://www.arca.fiocruz.br/bitstream/icict/57932/2/Anais7thISI2023_42.pdf65f50a1690fe13e05b6a0fd850c93ccbMD52icict/579322023-04-26 16:55:56.501oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:55:56Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.en_US.fl_str_mv |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
title |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
spellingShingle |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis Castro, Vitória Fernandes de Esclerose Múltipla Bioterapêutico Anticorpos Monoclonais Multiple Sclerosis Biotherapeutic Monoclonal Antibodies Esclerose Múltipla Anticorpos Monoclonais |
title_short |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
title_full |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
title_fullStr |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
title_full_unstemmed |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
title_sort |
Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis |
author |
Castro, Vitória Fernandes de |
author_facet |
Castro, Vitória Fernandes de Aquino, Carolina Lessa Lima, Erykson Chaves, Beatriz Reis, Rafaella Almeida, Vinícius Cotta de Esteves, Gabriela Santos Medeiros, Marco Alberto |
author_role |
author |
author2 |
Aquino, Carolina Lessa Lima, Erykson Chaves, Beatriz Reis, Rafaella Almeida, Vinícius Cotta de Esteves, Gabriela Santos Medeiros, Marco Alberto |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Castro, Vitória Fernandes de Aquino, Carolina Lessa Lima, Erykson Chaves, Beatriz Reis, Rafaella Almeida, Vinícius Cotta de Esteves, Gabriela Santos Medeiros, Marco Alberto |
dc.subject.other.en_US.fl_str_mv |
Esclerose Múltipla Bioterapêutico Anticorpos Monoclonais |
topic |
Esclerose Múltipla Bioterapêutico Anticorpos Monoclonais Multiple Sclerosis Biotherapeutic Monoclonal Antibodies Esclerose Múltipla Anticorpos Monoclonais |
dc.subject.en.en_US.fl_str_mv |
Multiple Sclerosis Biotherapeutic Monoclonal Antibodies |
dc.subject.decs.en_US.fl_str_mv |
Esclerose Múltipla Anticorpos Monoclonais |
description |
Apresentador do material: Vitória Fernandes de Castro Tipo de material apresentado: Pôster |
publishDate |
2023 |
dc.date.accessioned.fl_str_mv |
2023-04-24T14:04:43Z |
dc.date.available.fl_str_mv |
2023-04-24T14:04:43Z |
dc.date.issued.fl_str_mv |
2023 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/conferenceObject |
format |
conferenceObject |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
CASTRO, V. F. de et al. Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICALS, 7., 2023, Rio de Janeiro. Annals of the Symposium: building pathways to accelerated the development of the national tecnhnological innovation ecosystem. Rio de Janeiro: Instituto de Tecnologia em Imunobiológicos, 2023. p. 42. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/57932 |
dc.identifier.doi.none.fl_str_mv |
10.35259/isi.2023_57932 |
identifier_str_mv |
CASTRO, V. F. de et al. Development and characterization of Anti-VLA4 Monoclonal Antibody as a potential biopharmaceutical for the treatment of Multiple Sclerosis. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICALS, 7., 2023, Rio de Janeiro. Annals of the Symposium: building pathways to accelerated the development of the national tecnhnological innovation ecosystem. Rio de Janeiro: Instituto de Tecnologia em Imunobiológicos, 2023. p. 42. 10.35259/isi.2023_57932 |
url |
https://www.arca.fiocruz.br/handle/icict/57932 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/57932/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/57932/2/Anais7thISI2023_42.pdf |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 65f50a1690fe13e05b6a0fd850c93ccb |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324919935696896 |